fb-pixelFDA to approve first gene-editing therapy Skip to main content

FDA approves first gene-editing therapy

Wednesday, December 6th • Segment

The breakthrough treatment, made by local drug firms, targets sickle cell disease. Reporter Jonathan Saltzman breaks down the life-changing medicine.